Ichiro Nonin
Keine laufenden Positionen mehr
Karriereverlauf von Ichiro Nonin
Ehemalige bekannte Positionen von Ichiro Nonin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KONAKA CO.,LTD. | Finanzdirektor/CFO | 31.01.2011 | - |
GE Capital Consumer Finance
GE Capital Consumer Finance Investment Banks/BrokersFinance Part of GE Aerospace, GE Capital Consumer Finance is a company that provides total healthcare solutions and develops products to improve people's lives. The company is based in Norwalk, CT. The company's cell therapy operating company, GC Labcell, has been developing its NK cell platform for over ten years and was the first to demonstrate the safety of fully allogeneic NK cells in patients. Labcell and its affiliate Cell occupy a state-of-the-art cell center with research labs, process development labs, and a GMP cell therapy manufacturing facility. GC Group, the parent company, aims to reduce greenhouse gas emissions and is Thailand's largest integrated petrochemical business. | Finanzdirektor/CFO | 31.01.2011 | - |
VIA HOLDINGS,INC. | Comptroller/Controller/Auditor | - | - |
Direktor/Vorstandsmitglied | 01.06.2009 | - | |
Finanzdirektor/CFO | 28.01.2011 | 01.04.2014 | |
Investor Relations Kontakt | 17.01.2013 | - |
Statistik
International
Japan | 3 |
Vereinigte Staaten | 2 |
Operativ
Director of Finance/CFO | 3 |
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Sektoral
Consumer Services | 2 |
Retail Trade | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VIA HOLDINGS,INC. | Consumer Services |
KONAKA CO.,LTD. | Retail Trade |
Private Unternehmen | 1 |
---|---|
GE Capital Consumer Finance
GE Capital Consumer Finance Investment Banks/BrokersFinance Part of GE Aerospace, GE Capital Consumer Finance is a company that provides total healthcare solutions and develops products to improve people's lives. The company is based in Norwalk, CT. The company's cell therapy operating company, GC Labcell, has been developing its NK cell platform for over ten years and was the first to demonstrate the safety of fully allogeneic NK cells in patients. Labcell and its affiliate Cell occupy a state-of-the-art cell center with research labs, process development labs, and a GMP cell therapy manufacturing facility. GC Group, the parent company, aims to reduce greenhouse gas emissions and is Thailand's largest integrated petrochemical business. | Finance |
- Börse
- Insiders
- Ichiro Nonin
- Erfahrung